126 related articles for article (PubMed ID: 10566026)
1. ALX 111. ALX1-11, PTH, parathyroid hormone (1-84)-Allelix, recombinant human parathyroid hormone, rhPTH(1-84).
Drugs R D; 1999 Mar; 1(3):211-2. PubMed ID: 10566026
[No Abstract] [Full Text] [Related]
2. ALX 111: ALX1-11, parathyroid hormone (1-84) - NPS Allelix, PREOS, PTH, recombinant human parathyroid hormone, rhPTH (1-84).
Adis International Ltd
Drugs R D; 2003; 4(4):231-5. PubMed ID: 12848587
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.
Henriksen K; Andersen JR; Riis BJ; Mehta N; Tavakkol R; Alexandersen P; Byrjalsen I; Valter I; Nedergaard BS; Teglbjaerg CS; Stern W; Sturmer A; Mitta S; Nino AJ; Fitzpatrick LA; Christiansen C; Karsdal MA
Bone; 2013 Mar; 53(1):160-6. PubMed ID: 23234813
[TBL] [Abstract][Full Text] [Related]
4. Recombinant full-length parathyroid hormone (1-84): profile report.
Moen MD; Scott LJ
BioDrugs; 2007; 21(3):205-8. PubMed ID: 17516717
[No Abstract] [Full Text] [Related]
5. Use of recombinant human parathyroid hormone(1-84) in patients with postmenopausal osteoporosis: a prospective, open-label, single-arm, multicentre, observational cohort study of the effects of treatment on quality of life and pain--the PROPOSE study.
Möricke R; Rettig K; Bethke TD
Clin Drug Investig; 2011; 31(2):87-99. PubMed ID: 21155613
[TBL] [Abstract][Full Text] [Related]
6. PREOS NPS (Allelix/Nycomed).
White H; Ahmad A
Curr Opin Investig Drugs; 2005 Oct; 6(10):1057-66. PubMed ID: 16259228
[TBL] [Abstract][Full Text] [Related]
7. Teriparatide. LY 333334, MN 10T, parathyroid hormone (1-34), parathyroid hormone (1-34)-Asahi, parathyroid hormone (1-34)-Eli Lilly, parathyroid hormone (1-34)-Rhône-Poulenc Rorer, teriparatide acetate, hPTH 1-34, Parathar.
Drugs R D; 1999 Mar; 1(3):222-4. PubMed ID: 10566031
[No Abstract] [Full Text] [Related]
8. Normochromic normocytic anemia in a postmenopausal woman with severe osteoporosis treated with intermittent parathyroid hormone.
Anastasilakis AD; Savvides M; Polyzos SA; Georgopoulos C; Delaroudis S
J Bone Miner Metab; 2010; 28(1):108-10. PubMed ID: 19578808
[TBL] [Abstract][Full Text] [Related]
9. Summaries for patients. Parathyroid hormone (1-84) and risk for spinal fractures in women with osteoporosis.
Ann Intern Med; 2007 Mar; 146(5):I20. PubMed ID: 17339614
[No Abstract] [Full Text] [Related]
10. A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in China.
Zhang XZ; Wang B; Yang J; Xuan M; Song LG; Li H; Guo XH; Lü XF; Xue QY; Yang GY; Ji QH; Shen J; Liu ZM; Li CJ; Wu TF; Tong XC; Jia Y
Chin Med J (Engl); 2009 Dec; 122(24):2933-8. PubMed ID: 20137477
[TBL] [Abstract][Full Text] [Related]
11. [A randomized, multicenter, active-controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with that of elcatonin in postmenopausal women with osteoporosis in China].
Zhang XZ; Song LG; Wang B; Yang J; Li H; Xuan M; Lei T; Guo XH; Lü XF; Xue QY; Yang GY; Ji QH; Shen J; Liu ZM; Li CJ; Wu TF; Xie HB; Tong JC
Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):662-6. PubMed ID: 20979784
[TBL] [Abstract][Full Text] [Related]
12. Recombinant full-length parathyroid hormone (1-84).
Moen MD; Scott LJ
Drugs; 2006; 66(18):2371-81; discussion 2382-5. PubMed ID: 17181378
[TBL] [Abstract][Full Text] [Related]
13. The rhPTH (1-34), but not elcatonin, increases bone anabolic efficacy in postmenopausal women with osteoporosis.
Zhang L; Yang M; Liu D; Guo C; Li L; Yang G
Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):361-6. PubMed ID: 22639400
[TBL] [Abstract][Full Text] [Related]
14. Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in China.
Li Y; Xuan M; Wang B; Yang J; Zhang H; Zhang XZ; Guo XH; Lü XF; Xue QY; Yang GY; Ji QH; Liu ZM; Li CJ; Wu TF; Sheng ZY; Li PQ; Tong JC
Chin Med J (Engl); 2013 Feb; 126(3):457-63. PubMed ID: 23422107
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability and pharmacokinetic study of recombinant human parathyroid hormone [rhPTH (1-84)] in Chinese healthy volunteers.
Li Q; Qiao J; Deng J; Zeng T; Zhou P; Li W
J Huazhong Univ Sci Technolog Med Sci; 2009 Aug; 29(4):431-4. PubMed ID: 19662357
[TBL] [Abstract][Full Text] [Related]
16. Emerging anabolic treatments for osteoporosis.
Rosen CJ; Rackoff PJ
Rheum Dis Clin North Am; 2001 Feb; 27(1):215-33, viii. PubMed ID: 11285997
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.
Kim ES; Keating GM
Drugs; 2015 Jul; 75(11):1293-303. PubMed ID: 26177893
[TBL] [Abstract][Full Text] [Related]
18. Risedronic acid. NE 58095, risedronate sodium, Actonel.
Drugs R D; 1999 Mar; 1(3):218-20. PubMed ID: 10566029
[No Abstract] [Full Text] [Related]
19. PTH analogues and osteoporotic fractures.
Verhaar HJ; Lems WF
Expert Opin Biol Ther; 2010 Sep; 10(9):1387-94. PubMed ID: 20629581
[TBL] [Abstract][Full Text] [Related]
20. Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women.
Tashjian AH; Chabner BA
J Bone Miner Res; 2002 Jul; 17(7):1151-61. PubMed ID: 12096828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
